Filing Details

Accession Number:
0001179110-20-011090
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-11-12 21:31:16
Reporting Period:
2020-11-09
Accepted Time:
2020-11-12 21:31:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1604821 Natera Inc. NTRA Services-Medical Laboratories (8071) 010894487
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1646382 Matthew Rabinowitz C/O Natera, Inc., 201 Industrial Road
Suite 410
San Carlos CA 94070
Executive Chairman Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-11-09 18,366 $79.05 271,634 No 4 S Indirect By RMDM Trust
Common Stock Disposition 2020-11-09 14,041 $79.83 257,593 No 4 S Indirect By RMDM Trust
Common Stock Disposition 2020-11-09 9,218 $80.76 248,375 No 4 S Indirect By RMDM Trust
Common Stock Disposition 2020-11-09 16,533 $82.00 231,842 No 4 S Indirect By RMDM Trust
Common Stock Disposition 2020-11-09 25,070 $82.88 206,772 No 4 S Indirect By RMDM Trust
Common Stock Disposition 2020-11-09 6,272 $83.75 200,500 No 4 S Indirect By RMDM Trust
Common Stock Disposition 2020-11-09 500 $84.50 200,000 No 4 S Indirect By RMDM Trust
Common Stock Disposition 2020-11-10 4,055 $74.86 195,945 No 4 S Indirect By RMDM Trust
Common Stock Disposition 2020-11-10 7,523 $75.89 188,422 No 4 S Indirect By RMDM Trust
Common Stock Disposition 2020-11-10 37,865 $77.03 150,557 No 4 S Indirect By RMDM Trust
Common Stock Disposition 2020-11-10 28,746 $77.92 121,811 No 4 S Indirect By RMDM Trust
Common Stock Disposition 2020-11-10 11,211 $78.80 110,600 No 4 S Indirect By RMDM Trust
Common Stock Disposition 2020-11-10 600 $79.54 110,000 No 4 S Indirect By RMDM Trust
Common Stock Disposition 2020-11-11 1,100 $76.01 108,900 No 4 S Indirect By RMDM Trust
Common Stock Disposition 2020-11-11 34,752 $77.62 74,148 No 4 S Indirect By RMDM Trust
Common Stock Disposition 2020-11-11 33,512 $78.16 40,636 No 4 S Indirect By RMDM Trust
Common Stock Disposition 2020-11-11 636 $79.21 40,000 No 4 S Indirect By RMDM Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By RMDM Trust
No 4 S Indirect By RMDM Trust
No 4 S Indirect By RMDM Trust
No 4 S Indirect By RMDM Trust
No 4 S Indirect By RMDM Trust
No 4 S Indirect By RMDM Trust
No 4 S Indirect By RMDM Trust
No 4 S Indirect By RMDM Trust
No 4 S Indirect By RMDM Trust
No 4 S Indirect By RMDM Trust
No 4 S Indirect By RMDM Trust
No 4 S Indirect By RMDM Trust
No 4 S Indirect By RMDM Trust
No 4 S Indirect By RMDM Trust
No 4 S Indirect By RMDM Trust
No 4 S Indirect By RMDM Trust
No 4 S Indirect By RMDM Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 572,574 Direct
Common Stock 613,496 Indirect By Matthew Rabinowitz Grantor Retained Annuity Trust
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 31, 2020. The Reporting Person is subject to a Lock-Up Letter Agreement that expires on November 10, 2020. The sale of shares is a permissible exemption under the terms of the Lock-Up Letter Agreement.
  2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.34 to $79.33 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. The RMDM Trust is an irrevocable spendthrift trust for the benefit of Mr. Rabinowitz and other discretionary beneficiaries, pursuant to Nevada Revised Statutes Chapter 166. Under the RMDM Trust, Mr. Rabinowitz has no enforceable rights to distributions. The RMDM Trust is a fully discretionary trust and the distribution decisions for the RMDM Trust are vested in a committee. Mr. Rabinowitz disclaims beneficial ownership except to the extent of his pecuniary interest therein.
  4. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.34 to $80.325 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.37 to $81.31 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  6. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.38 to $82.36 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  7. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.38 to $83.37 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  8. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.40 to $84.20 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  9. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.45 to $84.51 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  10. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on July 31, 2020.
  11. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.27 to $75.26 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  12. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.44 to $76.43 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  13. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.44 to $77.42 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  14. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.46 to $78.42 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  15. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.50 to $79.40 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  16. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.53 to $79.55 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  17. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.63 to $76.20 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  18. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.87 to $77.865 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  19. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.87 to $78.865 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  20. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.91 to $79.44 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  21. Mr. Rabinowitz is a trustee of the Matthew Rabinowitz Grantor Retained Annuity Trust, and has voting and dispositive power with respect to the reported shares. Mr. Rabinowitz disclaims beneficial ownership except to the extent of his pecuniary interest therein.